"Designing Growth Strategies is in our DNA"

Post-Traumatic Headache Market Size, Share and Global Trend By Drug Type (Anti-inflammatory drugs, Acetylsalicylic acid, Acetaminophen, Migraine-specific abortant triptan, Others), By Route of Administration (Oral, Injectable), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Geography Forecast till 2026

Region : Global | Report ID: FBI100619 | Status : Ongoing

 

KEY MARKET INSIGHTS

Headache refers to persistent or long-lasting pain or aches in the head region of the body. Headache is a common result of traumatic brain injuries and can persist for a long period, even after mild head trauma. Increased attention to traumatic brain injuries has raised concern on post-traumatic headache, one of the most common consequences of traumatic brain injuries. The International Headache Society defines post-traumatic headache like the one which develops within seven days after traumatic brain injury. Post-traumatic headache is often associated with symptoms such as insomnia, poor concentration, dizziness, sensitivity to noise and bright lights, fatigue, and many others. Violence, motor vehicle accidents, sports injuries, and falls are common incidents that result in traumatic brain injuries. According to the American Migraine Foundation, almost 1.7 million traumatic brain injuries occur every year in the United States, having a significant impact on the lives of the patients.


The growth in global post-traumatic headache market is being driven by the increase in the incidences of traumatic brain injuries and advancements in the treatment of post-traumatic headache. The major mergers and acquisitions are also expected to drive the global post-traumatic headache market. For example, in 2017, AstraZeneca partnered with Grunenthal for the global rights of Zomig outside Japan, which will enable Grunenthal to have a major portion of the global post-traumatic headache market by 2025.

To gain extensive insights into the market, Request for Customization


However, higher time duration and expenditure involved in a drug development process of post-traumatic headache is responsible for restraining the market growth in the forecast period. Also, stringent regulations imposed on approval of the drugs is another factor limiting the growth of post-traumatic headache market.


KEY PLAYERS COVERED


Some of the major companies that are present in the global post-traumatic headache market are Novartis AG, Johnson & Johnson Health Care Systems Inc., Impax Laboratories, LLC., AstraZeneca, Grunenthal, GlaxoSmithKline plc., Glenmark Pharmaceutical Inc., Pfizer Inc., Merck & Co., Inc., Aralez Pharmaceuticals Inc., and others.


SEGMENTATION


























SEGMENTATION



 DETAILS



By Drug Type



·         Anti-inflammatory drugs


·         Acetylsalicylic acid


·         Acetaminophen


·         Migraine-specific abortant triptan


·         Others



By Route of Administration



·         Oral


·         Injectable



By Distribution Channel



·         Hospital Pharmacies


·         Retail Pharmacies


·         Online Pharmacies



By Geography



·         North America (USA and Canada)


·         Europe (UK, Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)


·         Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)


·         Latin America (Brazil, Mexico, and Rest of Latin America)


·         Middle East & Africa (South Africa, GCC, and Rest of the Middle East & Africa)



 


Among the route of administration, the oral route is the most preferred by the doctors and research scientist in R&D as it has more advantages over the intravenous route for post-traumatic headache patients. The oral route is painless, convenient, and cheap compared to injections. This segment is anticipated to hold a major proportion of the post-traumatic headache market during the forecast period.


KEY INSIGHTS


Prevalence of traumatic brain injuries and post-traumatic headache for key countries


Overview of patent analysis


Pipeline analysis


Key mergers and acquisitions


REGIONAL ANALYSIS


Geographically, the global post-traumatic headache market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is anticipated to expand in the forecast period, owing to increased incidences of traumatic brain injuries, increased R&D for post-traumatic headache drugs, and advanced healthcare facilities. The global post-traumatic headache market is expected to expand in Europe and the Asia Pacific by 2025 as a result of growing awareness about post-traumatic care among the population.


Key Industry Developments    



  • In April 2019, VA Greater Los Angeles Healthcare System, a part of U.S. Department of Veterans Affairs completed its clinical trial for Abobotulinumtoxina in treatment against post-traumatic headache.
  • In September 2018, Teva Pharmaceutical Industries Ltd received U.S.FDA approval for its AJOVY, a humanized monoclonal antibody supplied in the form of injection for treatment of migraine in adults which can be a future treatment for post traumatic headache.

Post-Traumatic Headache Market Size, Share and Global Industry Trend Forecast till 2026
  • Ongoing
  • 2019
  • 2016-2018

    CHOOSE LICENSE TYPE

  • 4850
    6850
    8850

Personalize this Research

  • Granular Research on Specified Regions or Segments
  • Companies Profiled based on User Requirement
  • Broader Insights Pertaining to a Specific Segment or Region
  • Breaking Down Competitive Landscape as per Your Requirement
  • Other Specific Requirement on Customization

Healthcare Clients

Abbott
Intuitive_Surgical_logo
Sedana-Cyan-Black-Tag
lpsos
DAEWOONG

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . More info.
X